Market Place
Sourcing Support
Enforcement Report - Week of June 11, 2025
11 Jun 2025 //
FDA
Apotex`s Generics Ticagrelor Receives Tentative Approval in US
01 May 2025 //
FDA
Apotex`s Generics Ticagrelor Receives Approval in US
01 May 2025 //
FDA
Apotex`s Generics Mirabegron Receives Approval in US
08 Jan 2025 //
FDA
Drugmaker Apotex accuses Amarin of Vascepa monopoly in US lawsuit
18 Jun 2024 //
REUTERS
Apotex Launches Generic Fertility Treatment Cetrorelix In US
14 May 2024 //
PR NEWSWIRE
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
23 Apr 2024 //
REUTERS
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
Apotex`s Generic Apixaban Receives Approval in the U.S.
16 Feb 2024 //
FDA
Apotex`s Generic Macitentan Receives Approval in the U.S.
09 Jan 2024 //
FDA
Apotex`s Generic Nilotinib Hydrochloride Receives Approval in the U.S.
05 Jan 2024 //
FDA
Enforcement Report - Week of December 6, 2023
06 Dec 2023 //
FDA
Apotex`s Generic Teriparatide Receives Approval in the U.S.
16 Nov 2023 //
FDA
Enforcement Report - Week of June 14, 2023
14 Jun 2023 //
FDA
Enforcement Report - Week of May 17, 2023
17 May 2023 //
FDA
Enforcement Report - Week of March 15, 2023
15 Mar 2023 //
FDA
Health Canada Issues Recall of Apotex`s APO-AMITRIPTYLINE 10mg: NDMA Impurity
07 Feb 2023 //
HEALTH CANADA
Apotex`s Generic Cyclosporine A Receives Approval in the U.S.
12 Jan 2023 //
FDA
Jazz sues generics for infringement on cannabis-derived drug
06 Jan 2023 //
FIERCE PHARMA
Enforcement Report - Week of January 4, 2023
04 Jan 2023 //
FDA
Health Canada Issues Recall of Apotex`s Apo-Acyclovir Tablets
28 Jul 2022 //
HEALTH CANADA
Enforcement Report - Week of July 27, 2022
27 Jul 2022 //
FDA
Enforcement Report - Week of May 25, 2022
25 May 2022 //
FDA
Apotex Launches Affordable Generic Option to Treat Relapsing Remitting Multiple Sclerosis
17 May 2022 //
PRESS RELEASE
Apotex`s Generic Dasatinib Receives Approval in the US
23 Nov 2021 //
FDA
Product Donation Supports Clinical Study to Evaluate FDA-Approved Medications
07 Oct 2021 //
PRNEWSWIRE
Canadian Cancer Patients Have New Affordable Treatment Option
27 Sep 2021 //
NEWSWIRE
Apotex`s Generic Ceftaroline Fosamil Receives Approval In US
21 Sep 2021 //
FDA
Apotex`s Gneneric Icosapent Ethyl Receives Approval In US
30 Jun 2021 //
FDA
Enforcement Report - Week of April 14, 2021
14 Apr 2021 //
FDA
Enforcement Report - Week of February 17, 2021
17 Feb 2021 //
FDA
Enforcement Report - Week of June 24, 2020
24 Jun 2020 //
FDA
Health Canada Issues Recall of Apotex Inc`s APO-Metformin
13 Jun 2020 //
HEALTH CANADA
Apotex`s Generic Penicillamine Receive Approval in U.S
30 Apr 2020 //
FDA
Enforcement Report - Week of November 20, 2019
20 Nov 2019 //
FDA
Enforcement Report - Week of November 6, 2019
06 Nov 2019 //
FDA
Apotex`s Generic Doxycycline Hyclate Receives Approval in US
17 Apr 2019 //
FDA
Apotex Corp. Issues Recalls of Drospirenone and Ethinyl Estradiol Tablets
05 Mar 2019 //
FDA
TGA Issues Recall of Mylan Australia`s Dilart and Dilart HCT (valsartan)
25 Nov 2018 //
TGA
